Opiant Pharmaceuticals to Report Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 12, 2020

Rhea-AI Summary

Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) will report its Q3 2020 financial results on November 12, 2020, after market close. The management team will host a conference call at 4:30 p.m. ET on the same day, accessible by dial-in and webcast. Opiant is focused on developing medications for addictions and drug overdoses, having created the NARCAN® Nasal Spray.

Positive

• Company is developing medicines for addictions and overdoses, indicating potential market growth.
• Upcoming financial results presentation may provide insights into company performance.

Negative

• None.

SANTA MONICA, Calif., Oct. 27, 2020 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, today announced it will report its third quarter 2020 financial results after the financial markets close on Thursday November 12, 2020.  

The Company’s management team is scheduled to host a conference call and webcast at 4:30 p.m. ET on Thursday November 12, 2020. To access the call, please dial 877-407-0792 in the U.S. or 201-689-8263 outside the U.S. and provide the conference ID number: 13712206. To access the live webcast, please go to the investors section of Opiant’s website at http://ir.opiant.com/. Following the live webcast, an archived version of the call will be available on the website.

Thursday November 12 @ 4:30 pm ET
Domestic: International: Conference ID: Webcast:	877-407-0792 201-689-8263 13712206 http://ir.opiant.com/

About Opiant Pharmaceuticals, Inc.

Opiant Pharmaceuticals, Inc., the company that developed NARCAN® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose.
For more information visit: www.opiant.com.

Investor Relations Contacts:
Ben Atkins
VP of Corporate Communications and Investor Relations
batkins@opiant.com
(310) 598-5410

Dan Ferry
Managing Director
LifeSci Advisors, LLC
daniel@lifesciadvisors.com
(617) 430-7576

FAQ

When will Opiant Pharmaceuticals report its Q3 2020 financial results?

Opiant Pharmaceuticals will report its Q3 2020 financial results on November 12, 2020, after market close.

What time is the conference call for Opiant's Q3 2020 results?

The conference call for Opiant's Q3 2020 results is scheduled for 4:30 p.m. ET on November 12, 2020.

How can I access Opiant Pharmaceuticals' conference call?

You can access the conference call by dialing 877-407-0792 in the U.S. or 201-689-8263 internationally, using conference ID 13712206.

What is the focus of Opiant Pharmaceuticals' business?

Opiant Pharmaceuticals is focused on developing medicines for addictions and drug overdoses, including the NARCAN® Nasal Spray.